Curriculum Vitae
Specialty
- Medical Oncology
- Internal Medicine
Education
- Ph.D. (2010 Jul - 2019 Apr): College of Medicine, National Taiwan University, Graduate Institute of Clinical Medicine
- M.D. (1995 Jul - 2002 Jun): College of Medicine, National Taiwan University
Experience
- 2020 Feb - Present: Assistant Professor, Graduate Institute of Oncology, National Taiwan University College of Medicine
- 2014 Feb - 2020 Jan: Adjunct Instructor, Department of Internal Medicine, National Taiwan University Hospital
- 2010 Jul - Present: Attending Physician, Department of Oncology, National Taiwan University Hospital
- 2008 Jul - 2010 Jun: Attending Physician, Department of Oncology, National Taiwan University Hospital, Yun-Lin Branch
Selected Publications
- Yang SH, Huang CJ, Chiu SC, Kao HF, Lu LC, Shan YS, Kuo SH, Yeh KH. Improved survival with adding-on strategy after failure of nanoliposomal irinotecan plus 5-fluorouracil and leucovorin in metastatic pancreatic adenocarcinoma. J Formos Med Assoc. 2025 Mar 4:S0929-6646(25)00101-9
- Yang SH, Chen BB, Lee JC, Kuo YT, Kuo SH, Cheng AL, Yeh KH. Incorporating nivolumab with preceded gemcitabine and S-1 chemotherapy for patients of metastatic pancreatic cancer: a pilot study. Am J Cancer Res 2025;15(9):4108-4120
- Yang SH, Kuo SH, Lee JC, Chen BB, Shan YS, Tien YW, Chiu SC, Cheng AL, Yeh KH. Adding-on nivolumab to chemotherapy-stabilized patients is associated with improved survival in advanced pancreatic ductal adenocarcinoma. Cancer Immunol Immunother. 2024 Sep 9;73(11):227
- Peng SH, Chen BB, Kuo TC, Lee JC, Yang SH＊. Maintenance therapy of low-dose nivolumab, S-1, and leucovorin in metastatic pancreatic adenocarcinoma with a germline mutation of MSH6: A case report. Front Immunol. 2022 Dec 13;13:1077840. doi: 10.3389/fimmu.2022.1077840
- Yang SH, Lee JC, Chen BB, Kuo SH, Hsu C, Bai LY. Case Report: Maintenance nivolumab in complete responder after multimodality therapy in metastatic pancreatic adenocarcinoma. Front Immunol. 2022 Apr 28;13:870406
- Yang SH, Chiang NJ, Chiu SC, Chou WC, Bai LY, Li CP, Su YY, Chiu TJ, Chuang SC, Peng CM, Chan DC, Chen JS, Yen CJ, Chen YY, Chiu CF, Chen LT, Shan YS. The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan. Am J Cancer Res. 2022 Apr 15;12(4):1884-1898
- Yang SH, Lu LC, Kao HF, Chen BB, Kuo TC, Kuo SH, Tien YW, Bai LY, Cheng AL, Yeh KH. Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma. Oncoimmunology. 2021 Sep 27;10(1):1973710
